Pranidipine enhances relaxation produced by endothelium-derived relaxing factor in carotid artery

Citation
M. Koshita et al., Pranidipine enhances relaxation produced by endothelium-derived relaxing factor in carotid artery, EUR J PHARM, 385(2-3), 1999, pp. 191-197
Citations number
22
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
385
Issue
2-3
Year of publication
1999
Pages
191 - 197
Database
ISI
SICI code
0014-2999(199912)385:2-3<191:PERPBE>2.0.ZU;2-R
Abstract
The effects of pranidipine, a novel dihydropyridine-type Ca2+-channel antag onist, on acetylcholine-induced endothelium-dependent relaxation were inves tigated in isolated carotid artery of the guinea-pig. In arteries contracte d with high-K+ solution ([K+](0) = 28.8 mM) containing noradrenaline, the r elaxation was inhibited by N-omega-nitro-L-arginine, indicating an involvem ent of endothelium-derived relaxing factor. Pranidipine (10(-9)-10(-7) M) a ugmented the relaxation in a concentration-dependent manner. Sodium nitropr usside produced a relaxation in arteries contracted with high-K+ solution c ontaining noradrenaline, in an endothelium-independent manner, and the rela xation was enhanced by pranidipine. 1H-[1,2,4] oxadiazolo [4,3-a] quinoxali n-1-one (ODQ), an inhibitor of nitric oxide-sensitive guanylate cyclase, at tenuated the relaxation produced by acetylcholine or sodium nitroprusside. In the presence of ODQ, pranidipine did not enhance the acetylcholine-induc ed relaxation. The relaxation produced by endothelium-derived hyperpolarizi ng factor was inhibited by pranidipine, with no alteration of the hyperpola rization. Thus, pranidipine augments the nitric oxide-induced relaxation. p ossibly by enhancing the mechanisms related to cyclic GMP. (C) 1999 Elsevie r Science B.V. All rights reserved.